Advanced Mobile Iv

The American healthcare system has a utilization problem. Millions of people need hydration therapy, immune support, nutrient replenishment, and recovery treatment but cannot or will not spend hours in urgent care waiting rooms or hospital emergency departments to receive it. Advanced Mobile IV was built to solve exactly that problem. Founded in November 2021 by two registered nurses, Holly Hansen and Ashley Yardley, in St. George, Utah, the company operationalized a simple but powerful idea: bring clinical-grade IV therapy directly to patients wherever they are, whether at home, in a hotel room, at an office, or at a sporting event. Hansen serves as Co-Owner and Chief Nursing Officer, bringing direct clinical authority to the brand's protocols, while Medical Director Dr. Paul Nielson, a family practitioner with over 44 years of experience specializing in preventative care, provides the medical oversight infrastructure that separates Advanced Mobile IV from unregulated wellness pop-ups. The company began franchising in May 2022, less than six months after its November 2021 founding, demonstrating the founders' intent to scale rapidly through a capital-efficient franchise model rather than through company-owned expansion. By mid-2025, the Advanced Mobile IV franchise network had grown to approximately 25 locations nationwide, with 29 units awarded since franchising began and 4 new franchise awards recorded in the most recent 12-month reporting period. According to 2024 Franchise Disclosure Document data, the system includes 16 franchised units and 1 company-owned unit across 7 states, with the heaviest concentration of 12 locations in the western United States. States with confirmed Advanced Mobile IV franchise presence include Arizona, Florida, Kentucky, Nebraska, Nevada, Texas, and Utah. This is not a brand at the end of its growth curve. It is a brand at the beginning of a very steep one, operating in a market that barely existed as a consumer category a decade ago and is now measured in billions of dollars annually.

The market that Advanced Mobile IV competes in is experiencing one of the most sustained, multi-factor growth cycles in the wellness sector. The global mobile IV therapy market was valued at USD 2.41 billion in 2024 and is projected to reach USD 4.41 billion by 2032, representing a compound annual growth rate of approximately 7.85%. The broader IV hydration therapy market, which encompasses clinic-based and mobile delivery, is estimated at USD 2.94 billion in 2025 and is forecast to expand to USD 4.60 billion by 2030 at an 8.9% CAGR. Within these figures, the U.S. market alone demonstrates even more aggressive momentum: the domestic mobile IV hydration therapy market was valued at USD 568.25 million in 2024 and is projected to reach approximately USD 1.56 billion by 2034, reflecting a 10.6% CAGR over the forecast period from 2025 to 2034. North America currently dominates the global mobile IV market, driven by advanced concierge service models and high digital adoption rates among consumers who prefer same-day scheduling through telehealth-connected platforms. The concierge and mobile service delivery segment is the fastest-growing sub-segment within the entire IV hydration therapy category, carrying a projected CAGR of 12.8% through 2030, which exceeds both the global and domestic market averages. Consumer behavior underpins all of these numbers. Post-pandemic health awareness has permanently elevated demand for immune-boosting interventions, and non-medicated IV services, which face fewer regulatory restrictions and align with mainstream preventative health philosophy, dominated the market in 2024 and are expected to maintain the largest share going forward. Rising disposable income, urban wellness culture, and the widespread adoption of at-home and on-demand medical services are secular tailwinds that do not reverse on short economic cycles. For franchise investors evaluating category selection, mobile IV therapy carries the structural characteristics of a defensible, high-growth vertical.

The Advanced Mobile IV franchise investment is structured to reflect the asset-light, mobile nature of the business model, which distinguishes it meaningfully from brick-and-mortar health and wellness franchise concepts that require expensive commercial leases, build-out costs, and permanent staffing. The initial franchise fee ranges from $35,000 to $85,000 depending on market and agreement structure, with a commonly cited figure of $50,000 for standard territory agreements. This fee is paid upfront upon execution of the Franchise Agreement. The total initial investment range spans from approximately $56,000 to $141,060 at the lower tier, with a broader range cited in some disclosure periods extending to $69,300 to $248,860 depending on variables including nurse kit configuration, insurance, vehicle and transportation costs, and professional fees. To contextualize those numbers, the total initial investment for a traditional urgent care franchise or medispa concept routinely exceeds $500,000 to $1.5 million, making the Advanced Mobile IV franchise investment one of the more capital-efficient entry points in the healthcare services franchise category. Specific line-item expenditures within the total investment include initial nurse kits at $5,100 to $10,200, business licenses and permits at $100 to $500, office and computer equipment at $0 to $2,000, a software fee of $1,500, a medical director fee of $1,500, advertising materials at $2,000, insurance at $2,500 to $3,500, and vehicle and transportation at $0 to $4,000. The minimum liquid capital required is $50,000, with working capital requirements estimated between $4,000 and $10,000 to cover early operational expenses before revenue stabilizes. Ongoing fees include a royalty rate of 5.00% of gross sales, with some sources referencing a range extending to 7.5% depending on agreement structure, plus a national brand fund advertising contribution of 3.00%. The combined ongoing fee load of 8% at the standard royalty rate is competitive within the health and wellness franchise sector. Third-party financing options are available for qualified franchisees, and the low overhead model of the business, which does not require commercial real estate, substantially reduces both the borrowing requirement and the fixed cost burden during ramp-up.

The Advanced Mobile IV operating model is designed around maximum flexibility for the franchisee and maximum convenience for the client, which is the combination that drives both owner satisfaction and customer retention in service franchises. Daily operations for an Advanced Mobile IV franchisee involve coordinating appointment schedules, traveling to client locations with pre-packaged IV therapy kits, administering treatments under established clinical protocols, and managing client follow-up and rebooking. The business is home-based and fully mobile, which eliminates commercial rent as a cost category entirely and allows franchisees to operate with minimal fixed overhead from the first day of business. Staffing models vary by operator scale, but the business can be launched as a solo operator model where the franchisee-owner is also the treating nurse, then scaled with additional employed or contracted nurses as revenue grows. While a nursing or clinical background is beneficial, Advanced Mobile IV does not require franchisees to have a medical license to own the franchise, as the company's partnership model with medical directors and its trained nurse network handles clinical delivery. The company considers business development skills and sales capability to be equally important to clinical background for franchise success. Initial training consists of 29 total hours, broken into 14 hours of classroom instruction and 15 hours of on-the-job training, covering clinical protocols, business operations, marketing, and technology systems. Advanced Mobile IV supports franchisees through proprietary technology including custom electronic medical records software and supply tracking systems that provide real-time business visibility and operational efficiency. The support structure is described as a turnkey model encompassing full clinical, operational, and marketing support, with established supply partnerships that remove sourcing burden from franchisees. On the subject of territory, the Franchise Disclosure Document does not grant exclusive geographic territories to franchisees, meaning the franchisor retains flexibility to place additional units or operate company locations in proximity to existing franchisees, a disclosure point that prospective investors should review carefully with a franchise attorney during due diligence.

Advanced Mobile IV discloses financial performance representations in Item 19 of its Franchise Disclosure Document, which is a meaningful signal of transparency in a franchise category where many emerging brands choose not to make such disclosures. The average annual franchise revenue reported is $274,000, with gross margins of 63%, which would translate to approximately $172,620 in gross profit on an average-revenue unit. The net profit for an average franchise is reported at approximately $130,000 annually, representing a net profit margin of roughly 47% on average revenues, a figure that reflects the structural advantage of the mobile, low-overhead model. Top-performing mobile Advanced Mobile IV units have achieved annual revenues of $465,000, demonstrating meaningful upside for franchisees who successfully build their client base and referral networks. The average investment payback period is estimated at 10 to 12 months, which is exceptionally short compared to most franchise categories where two to four years is the norm. Breakeven is reported to occur at approximately 25 IV administrations per week, a volume threshold that franchisees can reach through a combination of direct consumer marketing, corporate wellness partnerships, and event-based deployments. The three-year return on investment is reported between 275% and 300%, a figure that, if validated through independent franchisee verification and consistent with actual operator experience, represents a compelling capital efficiency profile. One data point worth noting for due diligence is that an alternative gross sales figure of $119,763 appears in some reporting, which may reflect earlier-stage cohort performance, partial-year reporting, or a different calculation methodology, and prospective investors should request the most current FDD Item 19 disclosure to understand which figures reflect the most recent and relevant operating period. The spread between average and top performers, from $274,000 to $465,000, is meaningful but not extreme, suggesting that while market quality and operator execution matter, the model does not produce extreme performance divergence that would indicate high-risk variance.

Advanced Mobile IV has grown from a founding in November 2021 to approximately 25 open locations by May 2025, adding meaningful unit count in a short operating window while also building the corporate infrastructure necessary to support a franchised network at scale. The trajectory from 16 to 17 total units in the 2024 FDD reporting period to 25 open units and 29 awarded all time by mid-2025 indicates active net new unit formation, with 4 franchise awards recorded in the most recent 12-month period. The company's competitive moat rests on several pillars. First, the clinical credibility established by co-founders who are both registered nurses, supported by a medical director with 44 years of experience, creates a trust differential versus non-clinician-operated wellness brands. Second, the proprietary technology stack, including custom EMR software and supply tracking systems, creates operational efficiency that reduces franchisee burden and supports clinical compliance simultaneously. Third, the brand's service portfolio is strategically diversified beyond basic hydration to include energy boost protocols, immune support, memory and cognitive enhancement, the Myers Cocktail, peptide therapies, and semaglutide injection programs, which positions Advanced Mobile IV in the intersection of the IV therapy market and the fast-growing functional medicine and weight management markets. The company is also developing nonprofit initiatives to make services accessible to cancer patients and creating educational programs for young athletes, both of which function as brand authority builders and community integration strategies. These mission-driven programs expand the brand's addressable market while differentiating it from competitors who focus exclusively on the affluent wellness consumer segment. The mobile delivery model itself is a structural advantage given that the mobile and concierge service segment carries a 12.8% CAGR projection through 2030, outpacing the broader IV hydration market growth rate by a meaningful margin.

The ideal Advanced Mobile IV franchise candidate is a self-directed professional who combines clinical credibility or a strong appreciation for healthcare service delivery with entrepreneurial drive and active marketing capability. Franchisee Tangi Perry, a former Home Health and Hospice Nurse with over 15 years of clinical experience, purchased her Advanced Mobile IV franchise in November 2022 and transitioned to full-time operation within approximately six months, a timeline that illustrates both the ramp speed possible within the model and the self-motivation required to succeed. Perry has specifically identified the characteristics of an ideal Advanced Mobile IV operator as someone who is a self-starter, self-motivated, works well independently, and is a critical thinker, all attributes that reflect the reality of running a mobile, relationship-driven service business without a fixed retail location generating walk-in traffic. The current geographic footprint spans 7 confirmed states with heaviest concentration in the western United States, suggesting that significant white-space territory remains available in the South, Midwest, and Northeast for investors seeking markets with lower incumbent franchise density. The mobile, home-based format means that franchisees do not require commercial real estate experience or retail site selection expertise, and the relatively low initial investment starting at approximately $56,000 makes this franchise accessible to a broader candidate pool than most healthcare or wellness franchise categories. Multi-unit development is available for qualified operators who demonstrate operational competency in their initial franchise, which creates a pathway to scaled income for investors with management backgrounds or existing healthcare business experience. The franchise agreement structure and renewal terms should be reviewed directly in the current FDD with independent legal counsel, as territorial rights language is a particularly important disclosure point given that exclusive territory protection is not provided under the standard agreement.

For investors conducting serious due diligence on the Advanced Mobile IV franchise opportunity, the investment thesis rests on four intersecting factors: a validated and expanding total addressable market projected to reach USD 1.56 billion in the United States alone by 2034, a capital-efficient entry point starting near $56,000 that is substantially below the investment threshold of most healthcare franchise categories, disclosed unit economics showing average annual revenues of $274,000 with 63% gross margins and a reported 10-to-12-month payback period, and a mobile operating model that structurally eliminates the commercial rent burden that erodes margins in fixed-location health and wellness franchises. The brand is founder-led by clinicians with genuine operational credibility, supported by a medical director with 44 years of experience, and backed by proprietary technology infrastructure that supports both clinical compliance and business management. At 25 locations across the United States as of mid-2025, the network is early-stage, which means available territory is broad but also that investors are participating in a brand still building system-level proof points rather than acquiring into a fully validated, multi-hundred-unit network. That early-stage profile carries both the upside of territory availability and the due diligence responsibility of verifying franchisee experience and system performance through direct franchisee interviews. PeerSense provides exclusive due diligence data including SBA lending history, FPI score, location maps with Google ratings, FDD financial data, and side-by-side comparison tools that allow investors to benchmark Advanced Mobile IV against competing franchise opportunities in the mobile wellness and healthcare services categories with independent, data-driven precision. Explore the complete Advanced Mobile IV franchise profile on PeerSense to access the full suite of independent franchise intelligence data.